Challenging the drug-likeness dogma for new drug discovery in Tuberculosis

• Authors: Machado D, Girardini M, Viveiros M, Pieroni M
• Publication Year: 2018
• Journal: Frontiers in Microbiology
• Link: https://www.ncbi.nlm.nih.gov/pubmed/30018597

The emergence of multi- and extensively drug resistant tuberculosis worldwide poses a great threat to human health and highlight the need to discover and develop new, effective and inexpensive antituberculosis agents. High-throughput screening assays against well-validated drug targets and structure based drug design have been employed to discover new lead compounds. However, the great majority […]
Read More